Skip to content

Clinical trials

Completed Liver Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Status: Completed Country / region: China Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20086
20092
20101
20112
20122
20135
20144
20159
20163
20177
20182
20194
20203
20215
20226
20235
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou12
Sun Yat-sen University6
Bristol-Myers Squibb4
Bayer3
Chinese PLA General Hospital3
Guangxi Medical University3
Eastern Hepatobiliary Surgery Hospital2
Imunon2
Novartis Pharmaceuticals2
Zhejiang University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms73
Carcinoma, Hepatocellular31
Liver Diseases5
Digestive System Neoplasms4
Lung Neoplasms4
Breast Neoplasms3
Colorectal Neoplasms3
Pancreatic Neoplasms3
Stomach Neoplasms3
Adenocarcinoma2

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.